NCT03298334View on ClinicalTrials.gov

Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2029

Conditions
Cesarean Delivery Affecting NewbornObesity, ChildhoodIntestinal MicrobiomeMicrobiotaHost Microbial InteractionsGastrointestinal Microbiome
Interventions
BIOLOGICAL

Vaginal Seeding

A gauze containing the Mother's vaginal flora will be swabbed over the face and body of the neonate shortly after cesarean delivery.

OTHER

No Vaginal Seeding

A gauze carrying sterile saline will be swabbed over the face and body of the neonate shortly after cesarean delivery.

Trial Locations (1)

22042

RECRUITING

Inova Health System, Falls Church

Sponsors
All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

Rutgers University

OTHER

collaborator

Inova Health Care Services

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH